IMPROVED New Developments in Psoriasis 800x300Banner


This symposium will consist of nine sessions presenting updates on the most recent developments in the diagnosis and treatment of psoriasis and psoriatic arthritis and their relevance to patient care. Participants will have the opportunity to interact with a nationally and internationally renowned group of rheumatology and dermatology faculty.


Arthur Kavanaugh, MD
Professor of Clinical Medicine
Director, Center for Innovative Therapy
UC San Diego School of Medicine

Kevin D. Cooper, MD
Professor and Chair, Department of Dermatology at Case Western Reserve
University and University Hospitals Cleveland Medical Center


The goal of this activity is to increase clinician knowledge of new and emerging agents in the treatment of psoriasis and psoriatic arthritis, as well as strategies for selecting from the spectrum of available options based upon individual patient considerations, including the presence of comorbid conditions. The program aims to better equip clinicians with the knowledge necessary to help patients with psoriasis and psoriatic arthritis achieve better disease control and functional status, reduce disease progression, and improve long-term health outcomes.


This continuing medical education course is designed for dermatologists, rheumatologists, family practitioners, internal medicine physicians, primary care physicians, nurse practitioners, and physician assistants involved in the care of patients with psoriasis and psoriatic arthritis.

Participation in this event is free, but registration is encouraged.  There is a fee of $125 for receiving CME credit for this activity. Register on line by clicking HERE or contact Stephanie Ledbetter at

UAB School of Medicine designates this enduring material for a maximum of 6.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


 Registration Deadline

SOM Epilogue Menu